메뉴 건너뛰기




Volumn 62, Issue 5, 2013, Pages 517-524

High viral load and elevated angiogenic markers associated with increased risk of preeclampsia among women initiating highly active antiretroviral therapy in pregnancy in the Mma bana study, Botswana

(14)  Powis, Kathleen M a,b,c   McElrath, Thomas F d   Hughes, Michael D e   Ogwu, Anthony c   Souda, Sajini f   Datwyler, Saul A g   Widenfelt, Erik Von c   Moyo, Sikhulile c   Nádas, Marisa h   Makhema, Joseph c   Machakaire, Esther i   Lockman, Shahin b,c,d   Essex, Max b,c   Shapiro, Roger L b,c,j  


Author keywords

HAART; HIV 1; Preeclampsia; Pregnancy; Viral load

Indexed keywords

ABACAVIR PLUS LAMIVUDINE PLUS ZIDOVUDINE; LAMIVUDINE; LAMIVUDINE PLUS ZIDOVUDINE; LOPINAVIR; LOPINAVIR PLUS RITONAVIR; NEVIRAPINE; PLACENTAL GROWTH FACTOR; RITONAVIR; VASCULOTROPIN RECEPTOR 1; ZIDOVUDINE;

EID: 84876411048     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e318286d77e     Document Type: Article
Times cited : (29)

References (29)
  • 2
    • 2442601512 scopus 로고    scopus 로고
    • Methodological and technical issues related to the diagnosis, screening, prevention, and treatment of preeclampsia and eclampsia
    • Villar J, Say L, Shennan A, et al. Methodological and technical issues related to the diagnosis, screening, prevention, and treatment of preeclampsia and eclampsia. Int J Gynecol Obstet. 2004;85(suppl 1): S28-S41.
    • (2004) Int J Gynecol Obstet , vol.85 , Issue.SUPPL. 1
    • Villar, J.1    Say, L.2    Shennan, A.3
  • 3
    • 37449022729 scopus 로고    scopus 로고
    • Maternal infection and risk of preeclampsia: Systematic review and metaanalysis
    • Conde-Agudelo A, Villar J, Lindheimer M. Maternal infection and risk of preeclampsia: systematic review and metaanalysis. Am J Obstet Gynecol. 2008;198:7-22.
    • (2008) Am J Obstet Gynecol , vol.198 , pp. 7-22
    • Conde-Agudelo, A.1    Villar, J.2    Lindheimer, M.3
  • 5
    • 33645737208 scopus 로고    scopus 로고
    • WHO analysis of causes of maternal death: A systemic review
    • Khan KS, Wojdyla D, Say L, et al. WHO analysis of causes of maternal death: a systemic review. Lancet. 2006;367:1066-1074.
    • (2006) Lancet , vol.367 , pp. 1066-1074
    • Khan, K.S.1    Wojdyla, D.2    Say, L.3
  • 6
    • 84864216683 scopus 로고    scopus 로고
    • Public health perspectives of preeclampsia in developing countries: Implications for health system strengthening
    • Osungbade KO, Ige OK. Public health perspectives of preeclampsia in developing countries: implications for health system strengthening. J Pregnancy. 2011;2011:481095.
    • (2011) J Pregnancy , vol.2011 , pp. 481095
    • Osungbade, K.O.1    Ige, O.K.2
  • 7
    • 77649192925 scopus 로고    scopus 로고
    • The implications of autoimmunity and pregnancy
    • Borchers AT, Naguwa SM, Keen CL, et al. The implications of autoimmunity and pregnancy. J Autoimmun. 2010;34:J287-J299.
    • (2010) J Autoimmun , vol.34
    • Borchers, A.T.1    Naguwa, S.M.2    Keen, C.L.3
  • 8
    • 74949106574 scopus 로고    scopus 로고
    • Angiotensin receptor agonistic autoantibody is highly prevalent in preeclampsia: Correlation with disease severity
    • Siddiqui AH, Irani RA, Blackwell SC, et al. Angiotensin receptor agonistic autoantibody is highly prevalent in preeclampsia: correlation with disease severity. Hypertension. 2010;55:386-393.
    • (2010) Hypertension , vol.55 , pp. 386-393
    • Siddiqui, A.H.1    Irani, R.A.2    Blackwell, S.C.3
  • 9
    • 80052622829 scopus 로고    scopus 로고
    • Receptor-activating autoantibodies and disease: Preeclampsia and beyond
    • Xia Y, Kellems RE. Receptor-activating autoantibodies and disease: preeclampsia and beyond. Expert Rev Clin Immunol. 2011;7:659-674.
    • (2011) Expert Rev Clin Immunol , vol.7 , pp. 659-674
    • Xia, Y.1    Kellems, R.E.2
  • 10
    • 0037304932 scopus 로고    scopus 로고
    • Agonistic autoantibodies directed against the angiotensin II AT1 receptor in patients with preeclampsia
    • Wallukat G, Neichel D, Nissen E, et al. Agonistic autoantibodies directed against the angiotensin II AT1 receptor in patients with preeclampsia. Can J Physiol Pharmacol. 2003;81:79-83.
    • (2003) Can J Physiol Pharmacol , vol.81 , pp. 79-83
    • Wallukat, G.1    Neichel, D.2    Nissen, E.3
  • 11
    • 10744227199 scopus 로고    scopus 로고
    • Circulating angiogenic factors and the risk of preeclampsia
    • Levine RJ, Maynard SE, Qian C, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med. 2004;350:672-683.
    • (2004) N Engl J Med , vol.350 , pp. 672-683
    • Levine, R.J.1    Maynard, S.E.2    Qian, C.3
  • 12
    • 79551488222 scopus 로고    scopus 로고
    • Circulating angiogenic and antiangiogenic factors in women with eclampsia
    • Vaisbuch E, Whitty JE, Hassan SS, et al. Circulating angiogenic and antiangiogenic factors in women with eclampsia. Am J Obstet Gynecol. 2011;204:152e1-152e9.
    • (2011) Am J Obstet Gynecol , vol.204
    • Vaisbuch, E.1    Whitty, J.E.2    Hassan, S.S.3
  • 13
    • 31844455050 scopus 로고    scopus 로고
    • Circulating angiogenic factors in preeclampsia, gestational proteinuria, and preeclampsia superimposed on chronic glomerulonephritis
    • Masuyama H, Suwaki N, Nakatsukasa H, et al. Circulating angiogenic factors in preeclampsia, gestational proteinuria, and preeclampsia superimposed on chronic glomerulonephritis. Am J Obstet Gynecol. 2006;194: 551-556.
    • (2006) Am J Obstet Gynecol , vol.194 , pp. 551-556
    • Masuyama, H.1    Suwaki, N.2    Nakatsukasa, H.3
  • 14
    • 33745274791 scopus 로고    scopus 로고
    • Evaluation of placental growth factor and soluble Fms-like tyrosine kinase 1 receptor levels in mild and severe preeclampsia
    • Robinson CJ, Johnson DD, Chang EY, et al. Evaluation of placental growth factor and soluble Fms-like tyrosine kinase 1 receptor levels in mild and severe preeclampsia. Am J Obstet Gynecol. 2006;195:255-259.
    • (2006) Am J Obstet Gynecol , vol.195 , pp. 255-259
    • Robinson, C.J.1    Johnson, D.D.2    Chang, E.Y.3
  • 15
    • 33847618756 scopus 로고    scopus 로고
    • Changes in circulating level of angiogenic factors from the first to second trimester as predictors of preeclampsia
    • 239.e1-239.e6
    • Vatten LJ, Eskild A, Nilsen TIL, et al. Changes in circulating level of angiogenic factors from the first to second trimester as predictors of preeclampsia. Am J Obstet Gynecol. 2007;196:239.e1-239.e6.
    • (2007) Am J Obstet Gynecol , vol.196
    • Vatten, L.J.1    Eskild, A.2    Nilsen, T.I.L.3
  • 16
    • 78049482011 scopus 로고    scopus 로고
    • Pregnancy-induced hypertension and preeclampsia: Levels of angiogenic factors in Malaysian women
    • Yelumalai S, Muniandy S, Omar SZ, et al. Pregnancy-induced hypertension and preeclampsia: levels of angiogenic factors in Malaysian women. J Clin Biochem Nutr. 2010;47:191-197.
    • (2010) J Clin Biochem Nutr , vol.47 , pp. 191-197
    • Yelumalai, S.1    Muniandy, S.2    Omar, S.Z.3
  • 17
    • 78149431733 scopus 로고    scopus 로고
    • Soluble fms-like tyrosine kinase 1 (sFlt-1), endoglin and placental growth factor (PlGF) in preeclampsia among high risk pregnancies
    • Powers RW, Jeyabalan A, Clifton RG, et al. Soluble fms-like tyrosine kinase 1 (sFlt-1), endoglin and placental growth factor (PlGF) in preeclampsia among high risk pregnancies. PLoS One. 2010;5:e13263.
    • (2010) PLoS One , vol.5
    • Powers, R.W.1    Jeyabalan, A.2    Clifton, R.G.3
  • 18
    • 34548446787 scopus 로고    scopus 로고
    • Angiogenic factors for the prediction of preeclampsia in high-risk women
    • 244e1-244.e8
    • Moore Simas TA, Crawford SL, Solitro MJ, et al. Angiogenic factors for the prediction of preeclampsia in high-risk women. Am J Obstet Gynecol. 2007;197:244.e1-244.e8.
    • (2007) Am J Obstet Gynecol , vol.197
    • Moore, S.T.A.1    Crawford, S.L.2    Solitro, M.J.3
  • 19
    • 0033081272 scopus 로고    scopus 로고
    • Obstetric and newborn outcomes in a cohort of HIV-infected pregnant women: A report of the women and infants transmission study
    • Stratton P, Tuomala RE, Abboud R, et al. Obstetric and newborn outcomes in a cohort of HIV-infected pregnant women: a report of the women and infants transmission study. J Acquir Immune Defic Syndr Hum Retrovirol. 1999;20:179-186.
    • (1999) J Acquir Immune Defic Syndr Hum Retrovirol , vol.20 , pp. 179-186
    • Stratton, P.1    Tuomala, R.E.2    Abboud, R.3
  • 20
    • 0037068948 scopus 로고    scopus 로고
    • Preeclampsia, antiretroviral therapy, and immune reconstitution
    • Wimalasundera RC, Larbalestier N, Smith JH, et al. Preeclampsia, antiretroviral therapy, and immune reconstitution. Lancet. 2002;360: 1152-1154.
    • (2002) Lancet , vol.360 , pp. 1152-1154
    • Wimalasundera, R.C.1    Larbalestier, N.2    Smith, J.H.3
  • 21
    • 29144502449 scopus 로고    scopus 로고
    • Increased risk of preeclampsia and fetal death in HIV-infected pregnant women receiving highly active antiretroviral therapy
    • Suy A, Martinez E, Coll O, et al. Increased risk of preeclampsia and fetal death in HIV-infected pregnant women receiving highly active antiretroviral therapy. AIDS. 2006;20:59-66.
    • (2006) AIDS , vol.20 , pp. 59-66
    • Suy, A.1    Martinez, E.2    Coll, O.3
  • 22
    • 73949121009 scopus 로고    scopus 로고
    • The safety of highly active antiretroviral therapy for HIV-positive pregnant mother and her baby: Is the more the merrier?
    • Martin F, Taylor GP. The safety of highly active antiretroviral therapy for HIV-positive pregnant mother and her baby: is "the more the merrier"? J Antimicrob Chemother. 2009;64:895-900.
    • (2009) J Antimicrob Chemother , vol.64 , pp. 895-900
    • Martin, F.1    Taylor, G.P.2
  • 23
    • 80052969116 scopus 로고    scopus 로고
    • Risk factors for very preterm delivery and delivery of very-small-for-gestational-age infants among HIV-exposed and HIV-unexposed infants in Botswana
    • Parekh N, Ribaudo H, Souda S, et al. Risk factors for very preterm delivery and delivery of very-small-for-gestational-age infants among HIV-exposed and HIV-unexposed infants in Botswana. Int J Gynecol Obstet. 2011;115:20-25.
    • (2011) Int J Gynecol Obstet , vol.115 , pp. 20-25
    • Parekh, N.1    Ribaudo, H.2    Souda, S.3
  • 24
    • 77953725982 scopus 로고    scopus 로고
    • Antiretroviral regimens in pregnancy and breast-feeding in Botswana
    • Shapiro R, Hughes M, Ogwu A, et al. Antiretroviral regimens in pregnancy and breast-feeding in Botswana. N Engl J Med. 2010;362:2282-2294.
    • (2010) N Engl J Med , vol.362 , pp. 2282-2294
    • Shapiro, R.1    Hughes, M.2    Ogwu, A.3
  • 26
    • 33748421660 scopus 로고    scopus 로고
    • Soluble endoglin and other circulating antiangiogenic factors in preeclampsia
    • Levine RJ, Lam C, Qian C, et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med. 2006;355:992-1005.
    • (2006) N Engl J Med , vol.355 , pp. 992-1005
    • Levine, R.J.1    Lam, C.2    Qian, C.3
  • 27
    • 7044239727 scopus 로고    scopus 로고
    • Soluble vascular endothelial growth factor receptor-1 (sflt-1) is increased throughout gestation in patients who have preeclampsia develop
    • McKeeman GC, Ardill JE, Caldwell CM, et al. Soluble vascular endothelial growth factor receptor-1 (sflt-1) is increased throughout gestation in patients who have preeclampsia develop. Am J Obstet Gynecol. 2004; 191:1240-1246.
    • (2004) Am J Obstet Gynecol , vol.191 , pp. 1240-1246
    • McKeeman, G.C.1    Ardill, J.E.2    Caldwell, C.M.3
  • 28
    • 69349103203 scopus 로고    scopus 로고
    • Obstetric and newborn infant outcomes in human immunodeficiency virus-infected women who receive highly active antiretroviral therapy
    • 315.e1-315.e5
    • Haeri S, Shauer M, Dale M, et al. Obstetric and newborn infant outcomes in human immunodeficiency virus-infected women who receive highly active antiretroviral therapy. Am J Obstet Gynecol. 2009;201:315. e1-315.e5.
    • (2009) Am J Obstet Gynecol , vol.201
    • Haeri, S.1    Shauer, M.2    Dale, M.3
  • 29
    • 84866059552 scopus 로고    scopus 로고
    • 9-11 November 2010. Geneva, Switzerland: World Health Organization, Available at, Accessed November 30, 2012
    • WHO. Towards the Elimination of Mother-to-Child Transmission of HIV: Report of a WHO Technical Consultation (9-11 November 2010). Geneva, Switzerland: World Health Organization; 2011. Available at: http://whqlibdoc. who.int/publications/2011/9789241501910-eng.pdf. Accessed November 30, 2012.
    • (2011) Towards the Elimination of Mother-to-Child Transmission of HIV: Report of a WHO Technical Consultation


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.